LCM
REGN icon

Landscape Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Landscape Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
464
-3,471
-88% -$2.36M 0.02% 563
2026
Q1 		$3.04M Buy
3,935
+3,503
+811% +$2.68M 0.19% 164
2025
Q4 		$333K Sell
432
-624
-59% -$424K 0.02% 531
2025
Q3 		$594K Buy
+1,056
New +$597K 0.04% 434
2025
Q2 		– Sell
-1,628
Closed -$1.03M – 801
2025
Q1 		$1.03M Buy
+1,628
New +$1.12M 0.09% 290
2019
Q4 		– Sell
-1,259
Closed -$349K – 798
2019
Q3 		$349K Sell
1,259
-699
-36% -$207K 0.03% 494
2019
Q2 		$613K Hold
1,958
– – 0.05% 370
2019
Q1 		$804K Sell
1,958
-103
-5% -$42.4K 0.08% 307
2018
Q4 		$770K Buy
2,061
+138
+7% +$50.5K 0.06% 330
2018
Q3 		$777K Buy
+1,923
New +$732K 0.06% 318
2018
Q1 		– Sell
-2,143
Closed -$806K – 634
2017
Q4 		$806K Buy
+2,143
New +$868K 0.07% 286
2014
Q2 		– Sell
-800
Closed -$240K – 350
2014
Q1 		$240K Buy
+800
New +$246K 0.32% 79

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Landscape Capital Management's REGN Position: Q2 2026 in Review

Landscape Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 88% in Q2 2026, selling an estimated $2.36M and leaving 464 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #563.

Landscape Capital Management first reported a position in REGN in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.04M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Landscape Capital Management held 464 shares of Regeneron Pharmaceuticals worth $289K as of Q2 2026.
  • Landscape Capital Management sold 3,471 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.36M.
  • Regeneron Pharmaceuticals made up 0.02% of Landscape Capital Management's portfolio in Q2 2026, its #563 holding.
  • Landscape Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
  • Landscape Capital Management's Regeneron Pharmaceuticals position peaked at $3.04M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.